Analysis of the cultured LMNs showed that in addition to maintaining ALS cellular markers, their survival rates mimicked ALS ...
The data shows that RNA interacts with a mitochondrial protein complex to trigger immune response pathways when viral RNA is ...
The company is launching a Phase Ib study that will test its first gene therapy in patients with locally advanced rectal ...
GEN presents data compiled by Morningstar's Morningstar Direct asset management platform for StockWatch of the top five ...
The U.S. CDMO recently signed its first contract with a customer, Serpin Pharma, to support their clinical manufacturing.
Novel vaccine platform improved protection against diverse influenza subtypes when tested in animal models and human organoids.
Researchers reveal new insights on the growth of craniopharyngioma and identified a potential therapeutic treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback